Burn wound infection-induced myeloid suppression: The role of prostaglandin E2, elevated adenylate cyclase, and cyclic adenosine monophosphate

Journal of Trauma - Injury, Infection and Critical Care

Volumn 44, Issue 3, 1998, Pages 469-474

  Gamelli, Richard L ^a   He, Li Ke ^a   Liu, Hong ^a   Ricken, John D ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENYLATE CYCLASE; ENZYME INHIBITOR; FORSKOLIN; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; ENZYME ACTIVITY; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; WOUND INFECTION;

EID: 0031903028     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199803000-00008     Document Type: Article

References (32)

1. Filkins JP. Cytokines and post-traumatic sepsis. In: Gamelli RL, Dries DJ, eds. Trauma 2000: Strategies for the New Millennium. Austin, Tex: RG Landes; 1992:81-84.
2. O'Riordain MG, Collins KH, Pilz M, et al. Modulation of macrophage hyperactivity improves survival in a burn-sepsis model. Arch Surg. 1992;127:152.
3. Fernandez-Botran R, Suzuki T. Prostaglandin-sensitive adenylate cyclase of a murine macrophage-like cell line (P388D1). II. Isolation and partial characterization of PGE2-binding proteins. J Immunol. 1984;133:2662.
4. Vairo G, Argyriou S, Bordun AM, et al. Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. J Biol Chem. 1990;265:2692.
5. Rock CO, Cleveland JL, Jackowski S. Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol Cell Biol. 1992;12:2351.
6. Gamelli RL, He LK, Liu H. Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma. 1994;37:339.
7. Gamelli RL, He LK, Liu H. Macrophage suppression of granulocyte and macrophage growth following burn wound infection. J Trauma. 1994;37:888.
8. Laurenza A, Khandelwal Y, De Souza NJ, et al. Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Mol Pharmacol. 1987;32:133.
9. Hei YJ, MacDonell KL, McNeill JH, et al. Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. Mol Pharmacol. 1991;39:233.
10. Gysbers JW, Rathbone MP. Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms. Neurosci Lett. 1996;220:175.
11. Kurland JI, Moore MAS. Modulation of hemopoiesis by prostaglandins. Exp Hematol. 1977;5:357.
12. Kurland JI, Bockman RS, Broxmeyer HE, et al. Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. Science. 1978;199:552.
13. 2. III. Induction of suppressor cells in marrow and spleen capable of mediating inhibition of CFU-GM proliferation. Blood. 1988;71:1633.
14. 2 induction of myelopoietic inhibitory activity. J Immunol. 1988;141:2714.
15. 2 in immune suppression following injury. Ann Surg. 1991;214:253.
16. Fletcher JR, Collins JN, Graves ED 3d, et al. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann Surg. 1993;217:668.
17. 2-induced immunoregulation mediated by cytokine production from cultures of human peripheral T lymphocytes. Immunopharmacol Immunotoxicol. 1996;18:27.
18. 2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology. 1995;84:446.
19. Strassman G, Patil-Koota V, Finkelman F, et al. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med. 1994;180:2365.
20. 2 is a potent inhibitor of human interleukin 12. J Exp Med. 1995;181:775.
21. 2 by cells of the hemopoietic micro environment in response to endotoxin. J Lab Clin Med. 1987;109:679.
22. 2 production by human bone marrow cells: a comparison with peripheral blood mononuclear cells. Tohoku J Exp Med. 1984;144:417.
23. Bourne HR, Lichtenstein LM, Melmon KL, et al. Modulation of inflammation and immunity by cyclic AMP. Science. 1974;184:19.
24. Reibman J, Haines K, Weissmann G. Alterations in cyclic nucleotides and the activation of neutrophils. Curr Top Membr Transp. 1990;35:399.
25. Bonney RJ, Davies P. Possible autoregulatory functions of the secretory products of mononuclear phagocytes. Contemp Top Immunobiol. 1984;13:199.
26. Horgan AF, O'Riordain DS, Chin DHL, et al. The role of cyclic adenosine monophosphate in the suppression of cellular immunity after thermal injury. Arch Surg. 1994;129:1284.
27. Heidenreich S, Otte B, Lang D, et al. Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells. J Leukocyte Biol. 1996;60:737.
28. Adams DO. LPS-initiated signal transduction pathways in macrophages. In: Morrison DC, Ryan JL, eds. Bacterial Endotoxic Lipopolysaccharides. Boca Raton, Fla: CRC Press; 1992:285-309.
29. Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem. 1992;267:7991.
30. Nusing RM, Klein T, Pfeilschifter J, et al. Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide-and prostanoid-forming pathways in cultured rat mesangial cells. Biochem J. 1996;313:617.
31. Feibich BL, Biber K, Leib K, et al. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. GLIA. 1996;18:152.
32. Pang L, Hoult JR. Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages. Biochem Pharmacol. 1997;53:493.